The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
New discoveries in the pathogenesis and classification of vitiligo
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CXCR3 ligands: redundant, collaborative and antagonistic functions
Groom, J. R., & Luster, A. D. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.158 · Cited by 1,001
Epidemiology of Vitiligo and Associated Autoimmune Diseases in Caucasian Probands and Their Families
Alkhateeb, A., Fain, P. R., Thody, A., Bennett, D. C., & Spritz, R. A. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00032.x · Cited by 728
Vitiligo: A comprehensive overview
Alikhan, A., Felsten, L. M., Daly, M., & Petronic-Rosic, V. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.061 · Cited by 708
Ezzedine, K., Lim, H. W., Suzuki, T., Katayama, I., Hamzavi, I., Lan, C. C. E., Goh, B. K., Anbar, T., Silva de Castro, C., Lee, A. Y., et al. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00997.x · Cited by 702
Self-citationHua, C., Boussemart, L., Mateus, C., Routier, E., Boutros, C., Cazenave, H., Viollet, R., Thomas, M., Roy, S., Benannoune, N., et al. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.2707 · Cited by 655
NALP1 in Vitiligo-Associated Multiple Autoimmune Disease
Jin, Y., Mailloux, C. M., Gowan, K., Riccardi, S. L., LaBerge, G., Bennett, D. C., Fain, P. R., & Spritz, R. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061592 · Cited by 630
A review of the worldwide prevalence of vitiligo in children/adolescents and adults
Krüger, C., & Schallreuter, K. U. (2012) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2011.05377.x · Cited by 571
Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients
van den Boorn, J. G., Konijnenberg, D., Dellemijn, T. A. M., Wietze van der Veen, J. P., Bos, J. D., Melief, C. J. M., Vyth-Dreese, F. A., & Luiten, R. M. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.32 · Cited by 543
Theveneau, E., & Mayor, R. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2011.12.041 · Cited by 535
Rashighi, M., Agarwal, P., Richmond, J. M., Harris, T. H., Dresser, K., Su, M.-W., Zhou, Y., Deng, A., Hunter, C. A., Luster, A. D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007811 · Cited by 518
Self-citationHigh Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo
Ogg, G. S., Rod Dunbar, P., Romero, P., Chen, J.-L., & Cerundolo, V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1203 · Cited by 460
Schallreuter, K. U., Moore, J., Wood, J. M., Beazley, W. D., Gaze, D. C., Tobin, D. J., Marshall, H. S., Panske, A., Panzig, E., & Hibberts, N. A. (1999) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsp.5640189 · Cited by 440
Harris, J. E., Harris, T. H., Weninger, W., John Wherry, E., Hunter, C. A., & Turka, L. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.463 · Cited by 389
Self-citationPlasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons
Gregorio, J., Meller, S., Conrad, C., Di Nardo, A., Homey, B., Lauerma, A., Arai, N., Gallo, R. L., DiGiovanni, J., & Gilliet, M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101102 · Cited by 367
Jin, Y., Andersen, G., Yorgov, D., Ferrara, T. M., Ben, S., Brownson, K. M., Holland, P. J., Birlea, S. A., Siebert, J., Hartmann, A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3680 · Cited by 355
Self-citationNarrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo
Scherschun, L., Kim, J. J., & Lim, H. W. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.114752 · Cited by 302
Lerner, A. B. (1959) · Journal of Investigative Dermatology · doi:10.1038/jid.1959.49 · Cited by 297
Poole, I. C. L., van den Wijngaard, R. M., Westerhof, W., & Das, P. K. (1996) · Europe PMC (PubMed Central) · Cited by 282
Vitiligo: interplay between oxidative stress and immune system
Laddha, N. C., Dwivedi, M., Mansuri, M. S., Gani, A. R., Ansarullah, M., Ramachandran, A. V., Dalai, S., & Begum, R. (2013) · Experimental Dermatology · doi:10.1111/exd.12103 · Cited by 273
Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark
Howitz, J. (1977) · Archives of Dermatology · doi:10.1001/archderm.113.1.47 · Cited by 255
Effect of vitiligo on self-reported health-related quality of life
Ongenae, K., Van Geel, N., De Schepper, S., & Naeyaert, J. M. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06456.x · Cited by 254
Segmental vitiligo: Clinical findings in 208 patients
Hann, S. K., & Lee, H. J. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90718-5 · Cited by 246
Innate immune mechanisms in vitiligo: danger from within
Richmond, J. M., Frisoli, M. L., & Harris, J. E. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.10.010 · Cited by 225
Self-citationPalermo, B., Campanelli, R., Garbelli, S., Mantovani, S., Lantelme, E., Brazzelli, V., Ardigó, M., Borroni, G., Martinetti, M., Badulli, C., et al. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01408.x · Cited by 223
The burden of vitiligo: Patient characteristics associated with quality of life
Linthorst Homan, M. W., Spuls, P. I., de Korte, J., Bos, J. D., Sprangers, M. A., & van der Veen, J. P. W. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.022 · Cited by 214
Ralf Paus, L., Schallreuter, K. U., Bahadoran, P., Picardo, M., Slominski, A., Elassiuty, Y. E., Kemp, E. H., Giachino, C., Liu, J. B., Luiten, R. M., et al. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00666_1.x · Cited by 211
Spritz, R. A., & Andersen, G. H. L. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2016.11.013 · Cited by 207
Toosi, S., Orlow, S. J., & Manga, P. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.181 · Cited by 203
Stress in patients with alopecia areata and vitiligo
Manolache, L., & Benea, V. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.02106.x · Cited by 201
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
Maeda, Y., Nishikawa, H., Sugiyama, D., Ha, D., Hamaguchi, M., Saito, T., Nishioka, M., Wing, J. B., Adeegbe, D., Katayama, I., et al. (2014) · Science · doi:10.1126/science.aaa1292 · Cited by 200
Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study
Gill, L., Zarbo, A., Isedeh, P., Jacobsen, G., Lim, H. W., & Hamzavi, I. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.08.063 · Cited by 199
Self-citationOngenae, K., Dierckxsens, L., Brochez, L., van Geel, N., & Naeyaert, J. M. (2005) · Dermatology · doi:10.1159/000084751 · Cited by 195
Prevalence of Vitiligo: Epidemiological Survey on the Isle of Bornholm, Denmark
Howitz, J. (1977) · Archives of Dermatology · doi:10.1001/archderm.1977.01640010049006 · Cited by 194
Cellular and developmental aspects of androgenetic alopecia
Jahoda, C. A. B. (1998) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00666.x · Cited by 192
Wang, X. X., Wang, Q. Q., Wu, J. Q., Jiang, M., Chen, L., Zhang, C. F., & Xiang, L. H. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14416 · Cited by 191
Willingness-to-pay and quality of life in patients with vitiligo
Radtke, M. A., Schäfer, I., Gajur, A., Langenbruch, A., & Augustin, M. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09091.x · Cited by 178
Reduced skin homing by functional Treg in vitiligo: Absence of Treg in vitiligo skin
Klarquist, J., Denman, C. J., Hernandez, C., Wainwright, D. J., Strickland, F. M., Overbeck, A., Mehrotra, S., Nishimura, M. I., & Le Poole, I. C. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00688.x · Cited by 176
Bassiouny, D. A., & Shaker, O. (2011) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2010.03972.x · Cited by 176
Lili, Y., Yi, W., Ji, Y., Yue, S., Weimin, S., & Ming, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037513 · Cited by 176
Vitiligo and Other Hypomelanoses of Hair and Skin
Ortonne, J.-P., Mosher, D. B., & Fitzpatrick, T. B. (1983) · Springer eBooks · doi:10.1007/978-1-4615-9272-3 · Cited by 175
Kroll, T. M., Bommiasamy, H., Boissy, R. E., Hernandez, C., Nickoloff, B. J., Mestril, R., & Caroline Le Poole, I. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23653.x · Cited by 175
Vitiligo, reactive oxygen species and T-cells
Glassman, S. J. (2011) · Clinical Science · doi:10.1042/cs20090603 · Cited by 175
Th17 Cells and Activated Dendritic Cells Are Increased in Vitiligo Lesions
Wang, C. Q. F., Cruz-Inigo, A. E., Fuentes-Duculan, J., Moussai, D., Gulati, N., Sullivan-Whalen, M., Gilleaudeau, P., Cohen, J. A., & Krueger, J. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018907 · Cited by 169
van den Boorn, J. G., Picavet, D. I., van Swieten, P. F., van Veen, H. A., Konijnenberg, D., van Veelen, P. A., van Capel, T., de Jong, E. C., Reits, E. A., Drijfhout, J. W., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.16 · Cited by 160
Type I interferon signature in the initiation of the immune response in vitiligo
Bertolotti, A., Boniface, K., Vergier, B., Mossalayi, D., Taieb, A., Ezzedine, K., & Seneschal, J. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12219 · Cited by 160
Self-citationSix Decades of Vitiligo Genetics: Genome-Wide Studies Provide Insights into Autoimmune Pathogenesis
Spritz, R. A. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.321 · Cited by 154
Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome
Parsad, D., Pandhi, R., Dogra, S., et al. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05097_9.x · Cited by 153
Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo
Mosenson, J. A., Zloza, A., Nieland, J. D., Garrett-Mayer, E. S., Eby, J. M., Huelsmann, E. J., Kumar, P., Denman, C. J., Lacek, A. T., Kohlhapp, F. J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005127 · Cited by 142
Yu, R., Broady, R. C., Huang, Y., Wang, Y., Yu, J., Gao, M., Levings, M. K., Wei, S., Zhang, S., Xu, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051040 · Cited by 140
Studies on vitiligo I. Epidemiological profile in Calcutta, India
Das, S., Majumder, P. P., Chakrabotry, R., Majumdar, T. K., Haldar, B., & Rao, D. C. (1985) · Genetic Epidemiology · doi:10.1002/gepi.1370020107 · Cited by 136
Vitiligo is not a cosmetic disease
Ezzedine, K., Sheth, V. M., Rodrigues, M. A., Eleftheriadou, V., Harris, J. E., Hamzavi, I. H., & Pandya, A. G. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.07.039 · Cited by 134
Self-citationNevus depigmentosus: Clinical features and histopathologic characteristics in 67 patients
Lee, H., Chun, Y., & Hann, S. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70524-4 · Cited by 132
Strassner, J. P., Rashighi, M., Refat, M. A., Richmond, J. M., & Harris, J. E. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.12.021 · Cited by 131
Self-citationOkamoto, T., Fujii, S., Huang, S. K. S., Hoon, D. S. �., Irie, R. F., Nizze, A. J., & Morton, D. L. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00411.x · Cited by 130
Sasaki, M., Kondo, M., Sato, K., Umeda, M., Kawabata, K., Takahashi, Y., Suzuki, T., Matsunaga, K., & Inoue, S. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12269 · Cited by 130
Harris, J. E. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2016.11.006 · Cited by 127
Self-citationGregg, R. K., Nichols, L. A., Chen, Y., Lu, B., & Engelhard, V. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902778 · Cited by 121
Ghosh, S., & Mukhopadhyay, S. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08815.x · Cited by 121
An epidemiologic case-control study in a population with vitiligo
Barona, M. I., Arrunátegui, A., Rafael Falabella, F., & Alzate, A. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)91282-7 · Cited by 119
HSP70i Accelerates Depigmentation in a Mouse Model of Autoimmune Vitiligo
Denman, C. J., McCracken, J., Hariharan, V., Klarquist, J. S., Oyarbide-Valencia, K., Guevara-Patino, J. A., & Poole, I. C. L. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.45 · Cited by 118
Harris, J. E. (2015) · Immunological Reviews · doi:10.1111/imr.12369 · Cited by 115
Self-citationPrimary Immune Deficiency Disorders Presenting as Autoimmune Diseases: IPEX and APECED
Vasconcelos, D. D. M., Costa-Carvalho, B. T., Torgerson, T. R., & Ochs, H. D. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9176-5 · Cited by 112
van Geel, N., Mollet, I. G., Schepper, S. D., Tjin, E. P. M., Vermaelen, K. Y., Clark, R. A., Kupper, T. S., Luiten, R. M., & Lambert, J. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00703.x · Cited by 104
Depigmentation therapies for normal skin in vitiligo universalis
AlGhamdi, K. M., & Kumar, A. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03876.x · Cited by 102
HSP70i is a critical component of the immune response leading to vitiligo
Mosenson, J. A., Zloza, A., Klarquist, J. S., Barfuss, A. J., Guevara-Patino, J. A., & Poole, I. C. L. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00916.x · Cited by 97
Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms
Gey, A., Diallo, A., Sénéschal, J., Léauté-Labrèze, C., Boralévi, F., Jouary, T., Taïeb, A., & Ezzedine, K. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12166 · Cited by 97
Self-citationEpidemiological study of vitiligo in Surat area, South Gujarat.
Nr, M., Kc, S., Théodore, C., Vp, V., & Ab, P. (1973) · PubMed · Cited by 93
Clinical significance of Koebner phenomenon in vitiligo
van Geel, N., Speeckaert, R., Wolf, J. D., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11158.x · Cited by 90
Ezzedine, K., Gauthier, Y., Léauté-Labrèze, C., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.08.031 · Cited by 89
Self-citationIizuka, H. (1994) · Journal of Dermatological Science · doi:10.1016/0923-1811(94)90057-4 · Cited by 84
Histopathologic Features in Vitiligo
Kim, Y. C., Kim, Y. J., Kang, H. Y., Sohn, S., & Lee, E. (2008) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e3181651511 · Cited by 84
Confetti-like depigmentation: A potential sign of rapidly progressing vitiligo
Sosa, J. J., Currimbhoy, S. D., Ukoha, U. T., et al. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.05.014 · Cited by 83
New insights in segmental vitiligo: case report and review of theories
van Geel, N., Mollet, I. G., Brochez, L., Dutré, M., Schepper, S. D., Verhaeghe, E., Lambert, J., & Speeckaert, R. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10650.x · Cited by 81
Brazzelli, V., Antoninetti, M., Palazzini, S., et al. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02278.x · Cited by 79
Clinical and histopathologic characteristics of trichrome vitiligo
Hann, S. K., Kim, Y. S., Yoo, J. H., et al. (2000) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(00)90170-1 · Cited by 75
Mochel, M. C., Ming, M. E., Imadojemu, S. E., Gangadhar, T. C., Schuchter, L. M., Elenitsas, R., Payne, A. S., & Chu, E. Y. (2016) · Journal of Cutaneous Pathology · doi:10.1111/cup.12735 · Cited by 74
Halo Nevi Association in Nonsegmental Vitiligo Affects Age at Onset and Depigmentation Pattern
Diallo, A. (2012) · Archives of Dermatology · doi:10.1001/archdermatol.2011.351 · Cited by 73
Clinical significance of Koebner’s phenomenon in vitiligo
van Geel, N., Speeckaert, R., Wolf, J. D., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11111.x · Cited by 71
Vitiligo and melanoma‐associated hypopigmentation (MAH):shared and discriminative features
Hartmann, A., Bedenk, C., Keikavoussi, P., Becker, J. C., Hamm, H., & Bröcker, E. (2008) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2008.06755.x · Cited by 62
Ezzedine, K., Diallo, A., Léauté-Labrèze, C., et al. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10709.x · Cited by 62
Self-citationVitiligo presentation in adults.
Mason, C., & Gawkrodger, D. J. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01779.x · Cited by 58
The distribution pattern of segmental vitiligo: clues for somatic mosaicism
van Geel, N., Speeckaert, R., Melsens, E., Toelle, S. P., Speeckaert, M. M., Schepper, S. D., Lambert, J., & Brochez, L. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12013 · Cited by 54
Garbelli, S., Mantovani, S., Palermo, B., & Giachino, C. (2005) · Pigment Cell Research · doi:10.1111/j.1600-0749.2005.00244.x · Cited by 53
Monobenzone‐induced depigmentation: from enzymatic blockade to autoimmunity
van den Boorn, J. G., Melief, C. J. M., & Luiten, R. M. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00878.x · Cited by 49
Activation of the Unfolded Protein Response in Vitiligo: The Missing Link?
Passeron, T., & Ortonne, J. P. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.328 · Cited by 47
In vivo vitiligo induction and therapy model: double‐blind, randomized clinical trial
van Geel, N., Speeckaert, R., Mollet, I. G., Schepper, S. D., Wolf, J. D., Tjin, E. P. M., Luiten, R. M., Lambert, J., & Brochez, L. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00922.x · Cited by 46
Hallaji, Z., Ghiasi, M., Eisazadeh, A., et al. (2012) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2012.00648.x · Cited by 44
Anbar, T. S., El-Badry, M. M., McGrath, J. A., & Abdel‐Azim, E. S. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13276 · Cited by 29
Use of permanent hair dyes and risk of vitiligo in women
Wu, S., Li, W., Cho, E., Harris, J. E., Speizer, F. E., & Qureshi, A. A. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12402 · Cited by 26
Self-citation
Cited by
Bergqvist, C., & Ezzedine, K. (2020) · Dermatology · doi:10.1159/000506103 · Cited by 799
Self-citationTwo Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
Rosmarin, D., Passeron, T., Pandya, A. G., Grimes, P., Harris, J. E., Desai, S. R., Lebwohl, M., Ruer-Mulard, M., Seneschal, J., Wolkerstorfer, A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2118828 · Cited by 316
Self-citationVitiligo: A focus on pathogenesis and its therapeutic implications
Bergqvist, C., & Ezzedine, K. (2021) · The Journal of Dermatology · doi:10.1111/1346-8138.15743 · Cited by 277
Self-citationVitiligo prevalence and quality of life among adults in Europe, Japan, and the USA
Bibeau, K., Pandya, A. G., Ezzedine, K., Jones, H., Gao, J., Lindley, A., & Harris, J. E. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18257 · Cited by 137
Self-citationFaraj, S., Kemp, E. H., & Gawkrodger, D. J. (2022) · Clinical and Experimental Immunology · doi:10.1093/cei/uxab002 · Cited by 94
Metadata
- Authors
- Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A. G., & Harris, J. E.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 77
- Issue
- 1
- Pages
- 1-13
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2626458389
- Cited by
- 476
- References
- 89
- FWCI
- 12.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.